Skip to main content
Erschienen in: Infection 4/2019

03.04.2019 | Review

A systematic review of latest evidence for antibiotic prophylaxis and therapy in oral and maxillofacial surgery

verfasst von: Sebastian Blatt, Bilal Al-Nawas

Erschienen in: Infection | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Especially in oral and maxillofacial surgery, where procedures involving the aero-digestive tract considered clean contaminated, surgical site infections (SSI) represent a severe health care burden. To improve implementation and methodological standard, an upgrade of the existing S1 guideline to a consensus-guided S3 guideline was initiated by the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V., AWMF, register number 067/009) and 25 collaborating medical societies.

Methods

A systematic literature search based on the Scottish Intercollegiate GL Network (SIGN)-search string for the guideline “Antibiotic prophylaxis in surgery” from 2014 was performed and equivalent exclusion/inclusion criteria were applied. An additional hand search provided latest evidence.

Results

In total, 80 clinical trials, retrospective studies, reviews, and meta-analysis were analyzed. For orthognathic surgery, prolonged antibiotic regimen may reduce risk for SSI but there is lack of evidence for the effects of short- vs. long-term therapy. For maxillofacial traumatology, antibiotic prophylaxis might reduce SSI but prolonged postoperative dosing shows no benefit. For clean-contaminated oncological interventions, anti-infectious therapy for 24 h only can reduce SSI; patients may not benefit from prolonged regimen. In contrast, for dentoalveolar procedures such as implantology or third molar removal, literature reveals ambivalent results.

Conclusion

In summary, consensus process of the planned S3 guideline is much in need to transfer the indecisive results for antibiotic prophylaxis in dentoalveolar surgery in clinical praxis and encourage adherence to guidelines.
Literatur
4.
Zurück zum Zitat SIGN SIGN. Antibiotic prophylaxis in surgery. (SIGN publication no104) 2014; 2008. SIGN SIGN. Antibiotic prophylaxis in surgery. (SIGN publication no104) 2014; 2008.
9.
Zurück zum Zitat Higgins JPT GS. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. In: The Cochrane Collaboration; 2011. Accessed 13 Mar 2017. Higgins JPT GS. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. In: The Cochrane Collaboration; 2011. Accessed 13 Mar 2017.
20.
Zurück zum Zitat Schaller B, Soong PL, Zix J, Iizuka T, Lieger O. The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomized, double-blind, placebo-controlled pilot clinical study. Part 2: mandibular fractures in 59 patients. Br J Oral Maxillofacial Surg. 2013;51:803–7. https://doi.org/10.1016/j.bjoms.2013.08.008.CrossRef Schaller B, Soong PL, Zix J, Iizuka T, Lieger O. The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomized, double-blind, placebo-controlled pilot clinical study. Part 2: mandibular fractures in 59 patients. Br J Oral Maxillofacial Surg. 2013;51:803–7. https://​doi.​org/​10.​1016/​j.​bjoms.​2013.​08.​008.CrossRef
23.
Zurück zum Zitat Soong PL, Schaller B, Zix J, Iizuka T, Mottini M, Lieger O. The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomised, double-blind, placebo-controlled pilot clinical study. Part 3: Le Fort and zygomatic fractures in 94 patients. Br J Oral Maxillofac Surg. 2014;52:329–33. https://doi.org/10.1016/j.bjoms.2014.01.010.CrossRefPubMed Soong PL, Schaller B, Zix J, Iizuka T, Mottini M, Lieger O. The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomised, double-blind, placebo-controlled pilot clinical study. Part 3: Le Fort and zygomatic fractures in 94 patients. Br J Oral Maxillofac Surg. 2014;52:329–33. https://​doi.​org/​10.​1016/​j.​bjoms.​2014.​01.​010.CrossRefPubMed
25.
Zurück zum Zitat Campos GB, Lucena EE, da Silva JS, Gomes PP, Germano AR. Efficacy assessment of two antibiotic prophylaxis regimens in oral and maxillofacial trauma surgery: preliminary results. Int J Clin Exp Med. 2015;8:2846–52.PubMedPubMedCentral Campos GB, Lucena EE, da Silva JS, Gomes PP, Germano AR. Efficacy assessment of two antibiotic prophylaxis regimens in oral and maxillofacial trauma surgery: preliminary results. Int J Clin Exp Med. 2015;8:2846–52.PubMedPubMedCentral
49.
Zurück zum Zitat Iglesias-Martin F, Garcia-Perla-Garcia A, Yanez-Vico R, Aced-Jimenez E, Arjona-Gerveno E, Gonzalez-Padilla JD, et al. Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars. Med Oral Patologia Oral y Cirugia Bucal. 2014;19:e612–5.CrossRef Iglesias-Martin F, Garcia-Perla-Garcia A, Yanez-Vico R, Aced-Jimenez E, Arjona-Gerveno E, Gonzalez-Padilla JD, et al. Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars. Med Oral Patologia Oral y Cirugia Bucal. 2014;19:e612–5.CrossRef
51.
Zurück zum Zitat Bezerra TP, Studart-Soares EC, Scaparo HC, Pita-Neto IC, Batista SH, Fonteles CS. Prophylaxis versus placebo treatment for infective and inflammatory complications of surgical third molar removal: a split-mouth, double-blind, controlled, clinical trial with amoxicillin (500 mg). J Oral Maxillofac Surg. 2011;69:e333–9. https://doi.org/10.1016/j.joms.2011.03.055.CrossRefPubMed Bezerra TP, Studart-Soares EC, Scaparo HC, Pita-Neto IC, Batista SH, Fonteles CS. Prophylaxis versus placebo treatment for infective and inflammatory complications of surgical third molar removal: a split-mouth, double-blind, controlled, clinical trial with amoxicillin (500 mg). J Oral Maxillofac Surg. 2011;69:e333–9. https://​doi.​org/​10.​1016/​j.​joms.​2011.​03.​055.CrossRefPubMed
64.
Zurück zum Zitat Arteagoitia MI, Barbier L, Santamaria J, Santamaria G, Ramos E. Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysis. Medicina Oral Patología Oral y Cirugia Bucal. 2016. https://doi.org/10.4317/medoral.21139.CrossRef Arteagoitia MI, Barbier L, Santamaria J, Santamaria G, Ramos E. Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysis. Medicina Oral Patología Oral y Cirugia Bucal. 2016. https://​doi.​org/​10.​4317/​medoral.​21139.CrossRef
73.
Zurück zum Zitat Nolan R, Kemmoona M, Polyzois I, Claffey N. The influence of prophylactic antibiotic administration on post-operative morbidity in dental implant surgery. A prospective double blind randomized controlled clinical trial. Clin Oral Implants Res. 2014;25:252–9. https://doi.org/10.1111/clr.12124.CrossRefPubMed Nolan R, Kemmoona M, Polyzois I, Claffey N. The influence of prophylactic antibiotic administration on post-operative morbidity in dental implant surgery. A prospective double blind randomized controlled clinical trial. Clin Oral Implants Res. 2014;25:252–9. https://​doi.​org/​10.​1111/​clr.​12124.CrossRefPubMed
77.
Zurück zum Zitat Arduino PG, Tirone F, Schiorlin E, Esposito M. Single preoperative dose of prophylactic amoxicillin versus a 2-day postoperative course in dental implant surgery: a two-centre randomised controlled trial. Eur J Oral Implantol. 2015;8:143–9.PubMed Arduino PG, Tirone F, Schiorlin E, Esposito M. Single preoperative dose of prophylactic amoxicillin versus a 2-day postoperative course in dental implant surgery: a two-centre randomised controlled trial. Eur J Oral Implantol. 2015;8:143–9.PubMed
80.
Zurück zum Zitat Cachovan G, Boger RH, Giersdorf I, Hallier O, Streichert T, Haddad M, et al. Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial. Antimicrob Agents Chemother. 2011;55:1142–7. https://doi.org/10.1128/AAC.01267-10.CrossRefPubMed Cachovan G, Boger RH, Giersdorf I, Hallier O, Streichert T, Haddad M, et al. Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial. Antimicrob Agents Chemother. 2011;55:1142–7. https://​doi.​org/​10.​1128/​AAC.​01267-10.CrossRefPubMed
81.
Zurück zum Zitat Gomez-Arambula H, Hidalgo-Hurtado A, Rodriguez-Flores R, Gonzalez-Amaro AM, Garrocho-Rangel A, Pozos-Guillen A. Moxifloxacin versus clindamycin/ceftriaxone in the management of odontogenic maxillofacial infectious processes: a preliminary, intrahospital, controlled clinical trial. J Clin Exp Dent. 2015;7:e634–9. https://doi.org/10.4317/jced.52627.CrossRefPubMedPubMedCentral Gomez-Arambula H, Hidalgo-Hurtado A, Rodriguez-Flores R, Gonzalez-Amaro AM, Garrocho-Rangel A, Pozos-Guillen A. Moxifloxacin versus clindamycin/ceftriaxone in the management of odontogenic maxillofacial infectious processes: a preliminary, intrahospital, controlled clinical trial. J Clin Exp Dent. 2015;7:e634–9. https://​doi.​org/​10.​4317/​jced.​52627.CrossRefPubMedPubMedCentral
Metadaten
Titel
A systematic review of latest evidence for antibiotic prophylaxis and therapy in oral and maxillofacial surgery
verfasst von
Sebastian Blatt
Bilal Al-Nawas
Publikationsdatum
03.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 4/2019
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01303-8

Weitere Artikel der Ausgabe 4/2019

Infection 4/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.